Post-transplant malignancies in minority populations

Area of Science:

• Transplantation research
• Oncology
• Health disparities

Background:

• Post-transplant malignancy (PTM) is a significant cause of morbidity and mortality after transplantation (TX).
• Prevalence and patterns of PTM in US minority populations (African-Americans, Native Americans, Asian Pacific Islanders, American Indians, Latino-Hispanics) are largely unknown.
• Existing data, such as from the Cincinnati Transplant Tumor Registry (CITTR), may not accurately reflect diverse populations due to assumptions of homogeneity and equal healthcare access.

Purpose of the Study:

• To investigate the unknown prevalence of PTM in US minority groups.
• To compare PTM patterns in African-Americans (AA) with the general population.
• To highlight the need for further research into PTM in diverse patient cohorts.

Main Methods:

• Analysis of data from the Howard University Hospital Transplant Center (HUHTC) focusing on African-American transplant recipients.
• Comparative analysis of cancer occurrence and types between AA patients and the general population (using CITTR data as a reference).
• Acknowledging the smaller HUHTC database size compared to CITTR.

Main Results:

• Cancer occurrence in the studied AA cohort was 3% (339 TX patients).
• Compared to the general population, AA patients showed a lower incidence of skin/lymphoid cancers (20% vs. 54%).
• AA patients exhibited a higher incidence of head and neck cancers (30% vs. 3%) and genitourinary cancers (30% vs. 8%).

Conclusions:

• PTM patterns may differ significantly among minority groups.
• African-Americans demonstrate distinct PTM profiles compared to the general transplant population.
• Further research is crucial to understand and address PTM disparities in minority populations to mitigate cancer risks.